GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Inventories, Raw Materials & Components

Taisho Pharmaceutical Holdings Co (TSE:4581) Inventories, Raw Materials & Components : 円25,369 Mil (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Inventories, Raw Materials & Components?

Taisho Pharmaceutical Holdings Co's inventories, raw materials & components for the quarter that ended in Dec. 2023 was 円25,369 Mil.

Taisho Pharmaceutical Holdings Co's quarterly raw materials increased from Jun. 2023 (円22,667 Mil) to Sep. 2023 (円24,677 Mil) and increased from Sep. 2023 (円24,677 Mil) to Dec. 2023 (円25,369 Mil).

Taisho Pharmaceutical Holdings Co's annual raw materials increased from Mar. 2021 (円15,529 Mil) to Mar. 2022 (円16,066 Mil) and increased from Mar. 2022 (円16,066 Mil) to Mar. 2023 (円19,577 Mil).


Taisho Pharmaceutical Holdings Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Inventories, Raw Materials & Components Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,485.00 13,577.00 15,529.00 16,066.00 19,577.00

Taisho Pharmaceutical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,164.00 19,577.00 22,667.00 24,677.00 25,369.00

Taisho Pharmaceutical Holdings Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines